Company Filing History:
Years Active: 2005
Title: David Sperandio: Innovator in Apoptosis Induction
Introduction
David Sperandio is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biochemistry, particularly in the area of apoptosis and cell death mechanisms. His work focuses on developing compounds that can effectively induce cell death in abnormal cells, which is crucial for treating various clinical conditions.
Latest Patents
David Sperandio holds a patent for "Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof." This invention is directed towards substituted 1,4-thiazepine and its analogs, represented by a specific general formula. The discovery highlights that these compounds are activators of caspases and inducers of apoptosis, making them valuable in medical applications where uncontrolled cell growth is a concern. He has 1 patent to his name.
Career Highlights
David is currently associated with Cytovia, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for diseases characterized by abnormal cell proliferation.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including John A Drewe and Sui Xiong Cai. These partnerships have enhanced the scope and impact of his research.
Conclusion
David Sperandio's innovative work in the field of apoptosis induction represents a significant advancement in medical science. His contributions are essential for developing therapies that target abnormal cell growth, showcasing the importance of innovation in healthcare.